Valiant Organics

Market Cap: Micro Cap
Industry: Specialty Chemicals
ISIN: INE565V01010
NSEID: VALIANTORG
BSEID: 540145

INR

267.15

-1.7 (-0.63%)

BSENSE

Dec 05

BSE+NSE Vol: 49.6 k

{
  "main_header": {
    "sid": 1002678,
    "name": "Valiant Organics",
    "stock_name": "Valiant Organics",
    "full_name": "Valiant Organics Ltd",
    "name_url": "stocks-analysis/valiant-organics",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "267.15",
    "chg": -1.7,
    "chgp": "-0.63%",
    "dir": -1,
    "prev_price": "268.85",
    "mcapval": "786.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540145,
    "symbol": "VALIANTORG",
    "ind_name": "Specialty Chemicals",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE565V01010",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "49.6 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/valiant-organics-1002678-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Valiant Organics falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-valiant-organics-fallingrising-3747354",
        "imagepath": "",
        "date": "2025-12-05 01:08:31",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>Valiant Organics’ gain of ₹12.80 on 04-Dec represents a significant intraday high, outperforming its sector by 4.71%. This rebound follows a brief period of falling prices, signalling renewed buying interest among investors. The stock’s performance over the past week has been positive, with a 6.48% increase, contrasting sharply with the Sensex’s marginal decline of 0.53% during the same period. This divergence suggests that Valiant Organics is attracting attention for reasons distinct from broader market trends.</p>\n<p>However, the stock’s recent strength should be viewed in the context of its longer-term returns. Over the past month, the share price has declined by 11.77%, while the Sensex gained 2.16%. Year-to-date, Valiant Organ..."
      },
      {
        "title": "Valiant Organics Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-upper-circuit-amid-strong-buying-pressure-3746734",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantOrganics_stocks_hitting_upper_circuit_3746734.png",
        "date": "2025-12-04 12:00:09",
        "description": "Valiant Organics Ltd witnessed robust buying interest on 4 December 2025, with its stock price hitting the upper circuit limit of ₹268.10, marking a maximum daily gain of 4.99%. This surge outpaced the Specialty Chemicals sector and broader market indices, reflecting heightened investor enthusiasm despite a recent period of subdued activity."
      },
      {
        "title": "Valiant Organics Surges with Unprecedented Buying Interest, Edging Towards Multi-Day Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-surges-to-upper-circuit-on-unprecedented-buying-interest-3746704",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantOrganics_only_buyers_3746704.png",
        "date": "2025-12-04 11:40:50",
        "description": "Valiant Organics Ltd has witnessed extraordinary buying momentum today, registering a 5.00% gain and hitting an intraday high of Rs 268.85. The stock’s performance stands in stark contrast to the broader market, with the Sensex advancing a modest 0.23%, underscoring a rare scenario where only buy orders populate the order book, signalling potential for a sustained multi-day upper circuit."
      },
      {
        "title": "Valiant Organics Technical Momentum Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-technical-momentum-shifts-amid-bearish-sentiment-3740303",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantOrganics_technicaldot_3740303.png",
        "date": "2025-12-02 08:10:48",
        "description": "Valiant Organics, a key player in the Specialty Chemicals sector, has experienced notable shifts in its technical momentum as recent market assessments reveal a transition from bearish to mildly bearish trends. This article analyses the evolving technical indicators, price movements, and comparative returns to provide a comprehensive view of the stock’s current positioning."
      },
      {
        "title": "Valiant Organics Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-upper-circuit-amid-strong-buying-pressure-3738673",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantOrganics_stocks_hitting_upper_circuit_3738673.png",
        "date": "2025-12-01 12:00:09",
        "description": "Valiant Organics Ltd, a micro-cap player in the specialty chemicals sector, witnessed robust buying interest on 1 Dec 2025, hitting its upper circuit limit with a 5.0% gain to close at ₹264.80. The stock outperformed its sector and broader market indices, reflecting heightened investor enthusiasm despite a backdrop of subdued delivery volumes and mixed moving average signals."
      },
      {
        "title": "Valiant Organics Sees Revision in Market Evaluation Amid Specialty Chemicals Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/valiant-organics-downgraded-to-sell-by-marketsmojo-amid-weak-financial-trends-3737996",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ValiantOrganics_mojoScore_3737996.png",
        "date": "2025-12-01 10:09:27",
        "description": "Valiant Organics, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance on its near-term prospects."
      },
      {
        "title": "Valiant Organics Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/valiant-organics-hits-lower-circuit-amid-heavy-selling-pressure-3717598",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ValiantOrganics_stocks_hitting_lower_circuit_3717598.png",
        "date": "2025-11-20 10:00:17",
        "description": "Valiant Organics Ltd, a micro-cap player in the Specialty Chemicals sector, witnessed a sharp decline on 20 Nov 2025 as its stock hit the lower circuit price limit, reflecting intense selling pressure and a significant intraday loss. The stock’s performance underperformed its sector peers and broader market indices, signalling a period of heightened volatility and investor caution."
      },
      {
        "title": "Is Valiant Organics overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-valiant-organics-overvalued-or-undervalued-3709985",
        "imagepath": "",
        "date": "2025-11-18 08:26:13",
        "description": "As of 17 November 2025, the valuation grade for Valiant Organics has moved from very attractive to attractive, indicating a shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 33.75, an EV to EBITDA of 12.54, and a PEG ratio of 0.20, which suggests that while the company may have growth potential, its current price does not adequately reflect that potential compared to its earnings.\n\nIn comparison to its peers, Valiant Organics' PE ratio is higher than Cipla's 22.81 but lower than Sun Pharma's 36.69, indicating that while it is relatively attractive within its segment, it still faces pressure from higher-valued competitors. Additionally, its ROCE of 4.56% and ROE of 3.18% are lower than those of many peers, which further supports the overvaluation verdict. Recent stock performance has lagged behind the Sensex, with a YTD return of -7.03% compared to..."
      },
      {
        "title": "Valiant Organics Q2 FY26: Profit Recovery Masks Underlying Revenue Weakness",
        "link": "https://www.marketsmojo.com/news/result-analysis/valiant-organics-q2-fy26-profit-recovery-masks-underlying-revenue-weakness-3718275",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ValiantOrganics_quaterlyResult_3718275.png",
        "date": "2025-11-15 10:54:52",
        "description": "Valiant Organics Ltd., a specialty chemicals manufacturer focused on agro intermediates and pharma applications, reported a consolidated net profit of ₹5.67 crores for Q2 FY26, marking a sharp turnaround from the ₹12.78 crore loss recorded in the same quarter last year. However, the recovery came amidst a concerning 23.04% sequential revenue decline, raising questions about the sustainability of the company's operational momentum. The stock, trading at ₹285.90 with a market capitalisation of ₹807.00 crores, has declined 19.97% over the past year, significantly underperforming both the Sensex and its specialty chemicals peer group."
      }
    ],
    "total": 240,
    "sid": "1002678",
    "stock_news_url": "https://www.marketsmojo.com/news/valiant-organics-1002678"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "29-Nov-2025",
      "details": "Please find our intimation in captioned subject",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "15-Nov-2025",
      "details": "Please find our intimation in captioned subject",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "15-Nov-2025",
      "details": "Please find our intimation in captioned subject",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Organics Ltd has declared <strong>10%</strong> dividend, ex-date: 10 Feb 23",
          "dt": "2023-02-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Valiant Organics Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 24 Dec 20",
          "dt": "2020-12-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Valiant Organics falling/rising?

2025-12-05 01:08:31

Short-Term Price Movement and Market Context

Valiant Organics’ gain of ₹12.80 on 04-Dec represents a significant intraday high, outperforming its sector by 4.71%. This rebound follows a brief period of falling prices, signalling renewed buying interest among investors. The stock’s performance over the past week has been positive, with a 6.48% increase, contrasting sharply with the Sensex’s marginal decline of 0.53% during the same period. This divergence suggests that Valiant Organics is attracting attention for reasons distinct from broader market trends.

However, the stock’s recent strength should be viewed in the context of its longer-term returns. Over the past month, the share price has declined by 11.77%, while the Sensex gained 2.16%. Year-to-date, Valiant Organ...

Valiant Organics Hits Upper Circuit Amid Strong Buying Pressure

2025-12-04 12:00:09

Valiant Organics Ltd witnessed robust buying interest on 4 December 2025, with its stock price hitting the upper circuit limit of ₹268.10, marking a maximum daily gain of 4.99%. This surge outpaced the Specialty Chemicals sector and broader market indices, reflecting heightened investor enthusiasm despite a recent period of subdued activity.

Valiant Organics Surges with Unprecedented Buying Interest, Edging Towards Multi-Day Upper Circuit

2025-12-04 11:40:50

Valiant Organics Ltd has witnessed extraordinary buying momentum today, registering a 5.00% gain and hitting an intraday high of Rs 268.85. The stock’s performance stands in stark contrast to the broader market, with the Sensex advancing a modest 0.23%, underscoring a rare scenario where only buy orders populate the order book, signalling potential for a sustained multi-day upper circuit.

Valiant Organics Technical Momentum Shifts Amid Market Challenges

2025-12-02 08:10:48

Valiant Organics, a key player in the Specialty Chemicals sector, has experienced notable shifts in its technical momentum as recent market assessments reveal a transition from bearish to mildly bearish trends. This article analyses the evolving technical indicators, price movements, and comparative returns to provide a comprehensive view of the stock’s current positioning.

Valiant Organics Hits Upper Circuit Amid Strong Buying Pressure

2025-12-01 12:00:09

Valiant Organics Ltd, a micro-cap player in the specialty chemicals sector, witnessed robust buying interest on 1 Dec 2025, hitting its upper circuit limit with a 5.0% gain to close at ₹264.80. The stock outperformed its sector and broader market indices, reflecting heightened investor enthusiasm despite a backdrop of subdued delivery volumes and mixed moving average signals.

Valiant Organics Sees Revision in Market Evaluation Amid Specialty Chemicals Sector Challenges

2025-12-01 10:09:27

Valiant Organics, a microcap player in the Specialty Chemicals sector, has experienced a revision in its market evaluation reflecting shifts in its fundamental and technical outlook. This adjustment follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, signalling a more cautious stance on its near-term prospects.

Valiant Organics Hits Lower Circuit Amid Heavy Selling Pressure

2025-11-20 10:00:17

Valiant Organics Ltd, a micro-cap player in the Specialty Chemicals sector, witnessed a sharp decline on 20 Nov 2025 as its stock hit the lower circuit price limit, reflecting intense selling pressure and a significant intraday loss. The stock’s performance underperformed its sector peers and broader market indices, signalling a period of heightened volatility and investor caution.

Is Valiant Organics overvalued or undervalued?

2025-11-18 08:26:13

As of 17 November 2025, the valuation grade for Valiant Organics has moved from very attractive to attractive, indicating a shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 33.75, an EV to EBITDA of 12.54, and a PEG ratio of 0.20, which suggests that while the company may have growth potential, its current price does not adequately reflect that potential compared to its earnings. In comparison to its peers, Valiant Organics' PE ratio is higher than Cipla's 22.81 but lower than Sun Pharma's 36.69, indicating that while it is relatively attractive within its segment, it still faces pressure from higher-valued competitors. Additionally, its ROCE of 4.56% and ROE of 3.18% are lower than those of many peers, which further supports the overvaluation verdict. Recent stock performance has lagged behind the Sensex, with a YTD return of -7.03% compared to...

Valiant Organics Q2 FY26: Profit Recovery Masks Underlying Revenue Weakness

2025-11-15 10:54:52

Valiant Organics Ltd., a specialty chemicals manufacturer focused on agro intermediates and pharma applications, reported a consolidated net profit of ₹5.67 crores for Q2 FY26, marking a sharp turnaround from the ₹12.78 crore loss recorded in the same quarter last year. However, the recovery came amidst a concerning 23.04% sequential revenue decline, raising questions about the sustainability of the company's operational momentum. The stock, trading at ₹285.90 with a market capitalisation of ₹807.00 crores, has declined 19.97% over the past year, significantly underperforming both the Sensex and its specialty chemicals peer group.